Skip to main content
SpringerLink
Log in

[68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

The data underlying this article will be shared on reasonable request to the corresponding author.

References

  1. Anderson CW, Bennett JJ. Clinical presentation and diagnosis of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am. 2016;25(2):363–74. https://doi.org/10.1016/j.soc.2015.12.003.

    Article  PubMed  Google Scholar 

  2. Maggio I, Mollica V, Brighi N, Lamberti G, Manuzzi L, Ricci AD, et al. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest. 2020;43(2):139–48. https://doi.org/10.1007/s40618-019-01091-w.

    Article  CAS  PubMed  Google Scholar 

  3. Prosperi D, Gentiloni SG, Panzuto F, Faggiano A, Russo VM, Caruso D, et al. Nuclear medicine and radiological imaging of pancreatic neuroendocrine neoplasms: a multidisciplinary update. J Clin Med. 2022;11(22):6836. https://doi.org/10.3390/jcm11226836.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Luo Y, Chen X. Imaging of insulinoma by targeting glucagonlike peptide-1 receptor. PET Clin. 2021;16(2):205–17. https://doi.org/10.1016/j.cpet.2020.12.008.

    Article  PubMed  Google Scholar 

  5. Pattison DA, Hicks RJ. Molecular imaging in the investigation of hypoglycaemic syndromes and their management. Endocr Relat Cancer. 2017;24(6):R203–21. https://doi.org/10.1530/ERC-17-0005.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This report was funded by National Natural Science Foundation of China (Grant number 82071961), and the medical and health guiding project in Xiamen (Grant number 3502Z20224ZD1001).

Author information

Author notes

  1. Wei Guo and Yuhang Chen contributed equally to this work

Authors and Affiliations

  1. Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen Cancer CenterXiamen, China

    Wei Guo, Xiaojiang He, Hao Fu, Jingxiong Huang & Haojun Chen

  2. The School of Clinical Medicine, Fujian Medical University, Fuzhou, China

    Yuhang Chen

Authors
  1. Wei Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuhang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaojiang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hao Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jingxiong Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haojun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haojun Chen.

Ethics declarations

Informed consent and ethical approval

This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Xiamen University, and written informed consent for publication of this report was obtained from the patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Oncology - General

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, W., Chen, Y., He, X. et al. [68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma. Eur J Nucl Med Mol Imaging 50, 2910–2911 (2023). https://doi.org/10.1007/s00259-023-06182-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06182-8

Search

Navigation